Peter Dannenbaum | VP, IR |
Ken Frazier | Chairman and CEO |
Rob Davis | CFO |
Dr. Roger Perlmutter | President, Merck Research Labs |
Kevin Ali | CEO, NewCo |
Frank Clyburn | Chief Commercial Officer |
Mike Nally | Chief Marketing Officer |
Chris Schott | J.P. Morgan |
Tim Anderson | Wolfe Research |
Steve Scala | Cowen |
Andrew Baum | Citi |
Louise Chen | Cantor |
Umer Raffat | Evercore |
Geoff Meacham | Bank of America |
Seamus Fernandez | Guggenheim |
Daina Graybosch | SVB Leerink |
David Risinger | Morgan Stanley |
Terence Flynn | Goldman Sachs |
Mara Goldstein | Mizuho |
Good morning. My name is Carlo and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Company Quarter Four Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.